Pacijenti i lekari se sukobljavaju oko neželjenih efekata hormonske kontrole rađanja

Što se tiče kontraceptivnih pilula , upotrebe , rizika i svega ima podosta studija , poslednji update februar 2022
https://www.ncbi.nlm.nih.gov/books/NBK430882/#article-26256.r2

22 reference od kojih bih izdvojila ovu o riziku od AIM i CVI

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494192/

References​

1.
Baird DT, Glasier AF. Hormonal contraception. N Engl J Med. 1993 May 27;328(21):1543-9. [PubMed]
2.
Maguire K, Westhoff C. The state of hormonal contraception today: established and emerging noncontraceptive health benefits. Am J Obstet Gynecol. 2011 Oct;205(4 Suppl):S4-8. [PubMed]
3.
Proctor ML, Roberts H, Farquhar CM. Combined oral contraceptive pill (OCP) as treatment for primary dysmenorrhoea. Cochrane Database Syst Rev. 2001;(4):CD002120. [PubMed]
4.
Arowojolu AO, Gallo MF, Lopez LM, Grimes DA, Garner SE. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. 2009 Jul 08;(3):CD004425. [PubMed]
5.
Shulman LP. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives. Am J Obstet Gynecol. 2011 Oct;205(4 Suppl):S9-13. [PubMed]
6.
ACOG Practice Bulletin No. 110: noncontraceptive uses of hormonal contraceptives. Obstet Gynecol. 2010 Jan;115(1):206-218. [PubMed]
7.
Powell A. Choosing the Right Oral Contraceptive Pill for Teens. Pediatr Clin North Am. 2017 Apr;64(2):343-358. [PubMed]
8.
Curtis KM, Jatlaoui TC, Tepper NK, Zapata LB, Horton LG, Jamieson DJ, Whiteman MK. U.S. Selected Practice Recommendations for Contraceptive Use, 2016. MMWR Recomm Rep. 2016 Jul 29;65(4):1-66. [PubMed]
9.
Kapp N, Curtis KM. Combined oral contraceptive use among breastfeeding women: a systematic review. Contraception. 2010 Jul;82(1):10-6. [PubMed]
10.
Korver T, Goorissen E, Guillebaud J. The combined oral contraceptive pill: what advice should we give when tablets are missed? Br J Obstet Gynaecol. 1995 Aug;102(8):601-7. [PubMed]
11.
Curtis KM, Tepper NK, Jatlaoui TC, Berry-Bibee E, Horton LG, Zapata LB, Simmons KB, Pagano HP, Jamieson DJ, Whiteman MK. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep. 2016 Jul 29;65(3):1-103. [PubMed]
12.
Nylander MC, Clausen HV. [Serious adverse effect of combined oral contraceptive pills among teenagers]. Ugeskr Laeger. 2014 Jun 23;176(26):V05130336. [PubMed]
13.
Roach RE, Helmerhorst FM, Lijfering WM, Stijnen T, Algra A, Dekkers OM. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev. 2015 Aug 27;(8):CD011054. [PMC free article] [PubMed]
14.
McCarthy KJ, Gollub EL, Ralph L, van de Wijgert J, Jones HE. Hormonal Contraceptives and the Acquisition of Sexually Transmitted Infections: An Updated Systematic Review. Sex Transm Dis. 2019 May;46(5):290-296. [PubMed]
15.
Tepper NK, Krashin JW, Curtis KM, Cox S, Whiteman MK. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection. MMWR Morb Mortal Wkly Rep. 2017 Sep 22;66(37):990-994. [PMC free article] [PubMed]
16.
Tayob Y, Adams J, Jacobs HS, Guillebaud J. Ultrasound demonstration of increased frequency of functional ovarian cysts in women using progestogen-only oral contraception. Br J Obstet Gynaecol. 1985 Oct;92(10):1003-9. [PubMed]
17.
Crawford P. Interactions between antiepileptic drugs and hormonal contraception. CNS Drugs. 2002;16(4):263-72. [PubMed]
18.
Committee on Gynecologic Practice. ACOG Committee Opinion Number 540: Risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills. Obstet Gynecol. 2012 Nov;120(5):1239-42. [PubMed]
19.
Cremer M, Phan-Weston S, Jacobs A. Recent innovations in oral contraception. Semin Reprod Med. 2010 Mar;28(2):140-6. [PubMed]
20.
Simmons KB, Haddad LB, Nanda K, Curtis KM. Drug interactions between non-rifamycin antibiotics and hormonal contraception: a systematic review. Am J Obstet Gynecol. 2018 Jan;218(1):88-97.e14. [PubMed]
21.
Weerasinghe M, Konradsen F, Eddleston M, Pearson M, Agampodi T, Storm F, Agampodi S. Overdose of oral contraceptive pills as a means of intentional self-poisoning amongst young women in Sri Lanka: considerations for family planning. J Fam Plann Reprod Health Care. 2017 Apr;43(2):147-150. [PubMed]
22.
Nanda K, Stuart GS, Robinson J, Gray AL, Tepper NK, Gaffield ME. Drug interactions between hormonal contraceptives and antiretrovirals. AIDS. 2017 Apr 24;31(7):917-952. [PMC free article] [PubMed]
 
nećemo ovde da preterujemo. To je rezervisano za moj forum Zanimljivoti ;)
Ne , ne radi se uopšte o tome. Računam da kada nešto kažeš , to možeš i da dokažeš. Reči ne predstavljaju ništa ukoliko nemaju pokriće, kada pričamo o tako ozbiljnoj temi. Upravo sam objavila listu stotinu istraživanja koja su objavljena na tu temu.
 
Ne , ne radi se uopšte o tome. Računam da kada nešto kažeš , to možeš i da dokažeš. Reči ne predstavljaju ništa ukoliko nemaju pokriće, kada pričamo o tako ozbiljnoj temi. Upravo sam objavila listu stotinu istraživanja koja su objavljena na tu temu.
ja sam pomenuo statine što je tema za sebe pa nisam hteo da širim raspravu o tome.
 
Što se tiče kontraceptivnih pilula , upotrebe , rizika i svega ima podosta studija , poslednji update februar 2022
https://www.ncbi.nlm.nih.gov/books/NBK430882/#article-26256.r2

22 reference od kojih bih izdvojila ovu o riziku od AIM i CVI

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494192/

References​

1.
Baird DT, Glasier AF. Hormonal contraception. N Engl J Med. 1993 May 27;328(21):1543-9. [PubMed]
2.
Maguire K, Westhoff C. The state of hormonal contraception today: established and emerging noncontraceptive health benefits. Am J Obstet Gynecol. 2011 Oct;205(4 Suppl):S4-8. [PubMed]
3.
Proctor ML, Roberts H, Farquhar CM. Combined oral contraceptive pill (OCP) as treatment for primary dysmenorrhoea. Cochrane Database Syst Rev. 2001;(4):CD002120. [PubMed]
4.
Arowojolu AO, Gallo MF, Lopez LM, Grimes DA, Garner SE. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. 2009 Jul 08;(3):CD004425. [PubMed]
5.
Shulman LP. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives. Am J Obstet Gynecol. 2011 Oct;205(4 Suppl):S9-13. [PubMed]
6.
ACOG Practice Bulletin No. 110: noncontraceptive uses of hormonal contraceptives. Obstet Gynecol. 2010 Jan;115(1):206-218. [PubMed]
7.
Powell A. Choosing the Right Oral Contraceptive Pill for Teens. Pediatr Clin North Am. 2017 Apr;64(2):343-358. [PubMed]
8.
Curtis KM, Jatlaoui TC, Tepper NK, Zapata LB, Horton LG, Jamieson DJ, Whiteman MK. U.S. Selected Practice Recommendations for Contraceptive Use, 2016. MMWR Recomm Rep. 2016 Jul 29;65(4):1-66. [PubMed]
9.
Kapp N, Curtis KM. Combined oral contraceptive use among breastfeeding women: a systematic review. Contraception. 2010 Jul;82(1):10-6. [PubMed]
10.
Korver T, Goorissen E, Guillebaud J. The combined oral contraceptive pill: what advice should we give when tablets are missed? Br J Obstet Gynaecol. 1995 Aug;102(8):601-7. [PubMed]
11.
Curtis KM, Tepper NK, Jatlaoui TC, Berry-Bibee E, Horton LG, Zapata LB, Simmons KB, Pagano HP, Jamieson DJ, Whiteman MK. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep. 2016 Jul 29;65(3):1-103. [PubMed]
12.
Nylander MC, Clausen HV. [Serious adverse effect of combined oral contraceptive pills among teenagers]. Ugeskr Laeger. 2014 Jun 23;176(26):V05130336. [PubMed]
13.
Roach RE, Helmerhorst FM, Lijfering WM, Stijnen T, Algra A, Dekkers OM. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev. 2015 Aug 27;(8):CD011054. [PMC free article] [PubMed]
14.
McCarthy KJ, Gollub EL, Ralph L, van de Wijgert J, Jones HE. Hormonal Contraceptives and the Acquisition of Sexually Transmitted Infections: An Updated Systematic Review. Sex Transm Dis. 2019 May;46(5):290-296. [PubMed]
15.
Tepper NK, Krashin JW, Curtis KM, Cox S, Whiteman MK. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection. MMWR Morb Mortal Wkly Rep. 2017 Sep 22;66(37):990-994. [PMC free article] [PubMed]
16.
Tayob Y, Adams J, Jacobs HS, Guillebaud J. Ultrasound demonstration of increased frequency of functional ovarian cysts in women using progestogen-only oral contraception. Br J Obstet Gynaecol. 1985 Oct;92(10):1003-9. [PubMed]
17.
Crawford P. Interactions between antiepileptic drugs and hormonal contraception. CNS Drugs. 2002;16(4):263-72. [PubMed]
18.
Committee on Gynecologic Practice. ACOG Committee Opinion Number 540: Risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills. Obstet Gynecol. 2012 Nov;120(5):1239-42. [PubMed]
19.
Cremer M, Phan-Weston S, Jacobs A. Recent innovations in oral contraception. Semin Reprod Med. 2010 Mar;28(2):140-6. [PubMed]
20.
Simmons KB, Haddad LB, Nanda K, Curtis KM. Drug interactions between non-rifamycin antibiotics and hormonal contraception: a systematic review. Am J Obstet Gynecol. 2018 Jan;218(1):88-97.e14. [PubMed]
21.
Weerasinghe M, Konradsen F, Eddleston M, Pearson M, Agampodi T, Storm F, Agampodi S. Overdose of oral contraceptive pills as a means of intentional self-poisoning amongst young women in Sri Lanka: considerations for family planning. J Fam Plann Reprod Health Care. 2017 Apr;43(2):147-150. [PubMed]
22.
Nanda K, Stuart GS, Robinson J, Gray AL, Tepper NK, Gaffield ME. Drug interactions between hormonal contraceptives and antiretrovirals. AIDS. 2017 Apr 24;31(7):917-952. [PMC free article] [PubMed]
i medju svim tim studijama, da li se priča o tome da pilule mogu da izazovu depresiju? (ono što je pisalo u uvodnom postu teme)
 
i medju svim tim studijama, da li se priča o tome da pilule mogu da izazovu depresiju? (ono što je pisalo u uvodnom postu teme)
Ima svega , ko oće da čita :lol:
evo ti jedna o depresiji i konraceptivnim pilulama , sprovedena na samo 4765 adolescenata u Americi
od 29.1.2019.

https://www.sciencedirect.com/science/article/abs/pii/S1047279718301595?via=ihub
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349422/

zaključak je da upotreba nije povezana sa povećanim rizikom od depresivnih poremećaja kod njih.
 
iz ovog članka

Dve švedske studije su otkrile da su žene koje su prepisivale OCP izložene povećanom riziku za naknadni recept za antidepresive. Prospektivna studija iz 2016. koja je koristila danski registar lekova pokazala je slične rezultate. Zabrinjavajuće je zbunjivanje po indikacijama; naime, da je veća verovatnoća da će ženama biti prepisane pilule za kontrolu rađanja za ublažavanje simptoma poremećaja raspoloženja, pa je veća verovatnoća da će te iste žene razviti depresiju.

Dalje, i dobijanje dijagnoze depresije, kao i primanje lekova za lečenje depresije, nažalost se dešava među samo manjim brojem pojedinaca koji doživljavaju depresiju; korišćenje podataka registra uvodi pogrešnu klasifikaciju.

Prema tome, očigledna veza između upotrebe OCP i dijagnoze depresije može se alternativno objasniti pristrasnošću nadzora - ženama koje redovno traže usluge lekara je veća verovatnoća da će im uopšte prepisivati lekove.

Nadalje, zbunjujući faktori na individualnom nivou, kao što je seksualno ponašanje, nisu dovoljno uzeti u obzir u registrima droga

...................
dakle, igra reči "mož da bude a ne mora da znači" (podebljano gore) koja ništa ne dokazuje već eventualno produbljuje nedoumice.
 
Žene , ne adolescenti , gde spada i priča koju si pročitao. Velika razlika.
Kod žena pušaća posle 35. , nepušača posle 40. , uopšteno govoreći se i ne daju ovi lekovi najpre zbog neželjenih kardiovaskularnih događaja. Ginekolog je lekar koji određuje kada, da li sme , koliko dugo , a to i uključuje obavezne kontrolne preglede.
 

Back
Top